| Literature DB >> 9853620 |
L Zeitlin1, S S Olmsted, T R Moench, M S Co, B J Martinell, V M Paradkar, D R Russell, C Queen, R A Cone, K J Whaley.
Abstract
The ability to produce monoclonal antibodies (Mabs) in plants offers the opportunity for the development of an inexpensive method of mucosal immunoprotection against sexually transmitted diseases. To investigate the suitability of plant-expressed Mabs for vaginal preventive applications, we compared a humanized anti-herpes simplex virus 2 (HSV-2) Mab expressed in mammalian cell culture with the same antibody expressed in soybean. We found these Mabs to be similar in their stability in human semen and cervical mucus over 24 h, their ability to diffuse in human cervical mucus, and their efficacy for prevention of vaginal HSV-2 infection in the mouse.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9853620 DOI： 10.1038/4344
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908